Evidence map›Paper›PMID 31068605›Full record

ArticleScientific reports2019

Neuralized family member NEURL1 is a ubiquitin ligase for the cGMP-specific phosphodiesterase 9A.

Kati Taal, Jürgen Tuvikene, Grete Rullinkov, Marko Piirsoo, Mari Sepp, Toomas Neuman, Richard Tamme, Tõnis Timmusk

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04865198 (Role of Neuralized1 and RGS14 Genes With ASD Patients), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04865198 completednot on this map

Role of Neuralized1 and RGS14 Genes With ASD Patients

TypeobservationalSponsorTC Erciyes UniversityRan2013 to 2014Enrolled60ConditionsAutism Spectrum Disorder, High-functioning Autism, HealthyArmsNeurl1 gene expression, RGS14 gene expression
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kati TaalDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.
Jürgen TuvikeneDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.
Grete RullinkovDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.
Marko PiirsooDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.ORCID http://orcid.org/0000-0002-9447-1350
Mari SeppDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.
Toomas NeumanProtobios LLC, 12618, Tallinn, Estonia.
Richard TammeDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia. richard.tamme@ttu.ee.
Tõnis TimmuskDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia. tonis.timmusk@ttu.ee.
Tallinn University of Technology · EEProtobios (Estonia) · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuralized functions as a positive regulator of the Notch pathway by promoting ubiquitination of Notch ligands via its E3 ligase activity, resulting in their efficient endocytosis and signaling. Using a yeast two-hybrid screen, we have identified a cGMP-hydrolysing phosphodiesterase, PDE9A, as a novel interactor and substrate of Neuralized E3 ubiquitin protein ligase 1 (NEURL1). We confirmed this interaction with co-immunoprecipitation experiments and show that both Neuralized Homology Repeat domains of NEURL1 can interact with PDE9A. We also demonstrate that NEURL1 can promote polyubiquitination of PDE9A that leads to its proteasome-mediated degradation mainly via lysine residue K27 of ubiquitin. Our results suggest that NEURL1 acts as a novel regulator of protein levels of PDE9A.

Indexed as

3',5'-Cyclic-AMP PhosphodiesterasesAnimalsCatalytic DomainCyclic GMPFemaleHEK293 CellsHumansImmunoprecipitationMaleNeuronsProteasome Endopeptidase ComplexProteolysisRatsRats, Sprague-DawleyTransfectionUbiquitin3',5'-Cyclic-AMP PhosphodiesterasesCyclic GMPNEURL1 protein, humanNEURL1 protein, ratPDE9A protein, humanPde9a protein, ratProteasome Endopeptidase ComplexUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID31068605
PMCPMC6506465
OpenAlexW2944340747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.